• $5M Donation From Grateful Patient Helps VCU Health Expand PF Care
  • What It Means When I Say I Had a ‘Bad Clinic Day’
  • Amgen to Acquire Rodeo Therapeutics, Preclinical Program for PF
  • Esbriet, Ofev Found to Benefit IPF Patients in Clinical Practice
  • FDA Approves Tyvaso, 1st Treatment Aiding Exercise With PH-ILD
  • KL-6 Protein Found to Be a Promising Biomarker for IPF Prognosis
  • How COVID-19 Has Shifted People’s Lives and Habits
  • Cost of Rare Diseases in US? Nearly $1 Trillion in 2019, EveryLife Foundation Finds
  • Ofev’s Ability to Slow Decline in Progressing ILDs Not Dependent on Prior Therapy
  • IPF Diagnosis and Treatment Changing for Better in UK, Registry Study Finds
  • Lassen, Cedars Sinai Partner to Advance Antibody Therapies for IPF
  • Finding Peace and Power With Breathing Exercises